These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38910478)

  • 1. Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches.
    Jiang J; Lu J; Feng Y; Zhao Y; Su J; Zeng T; Chen Y; Shen K; Jia Y; Lin S
    Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38910478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of immune escape-related genes in lung adenocarcinoma.
    Jia HR; Li WC; Wu L
    Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification.
    Chen X; Zhao X; Li D; Zha W
    Curr Med Chem; 2024 Aug; ():. PubMed ID: 39108112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic model for
    Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C
    J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma.
    Zheng Q; Li M; Qiu Y; Yang J; Cao Y
    Heliyon; 2024 Jan; 10(1):e23828. PubMed ID: 38187235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma.
    Wu Y; Luo J; Li H; Huang Y; Zhu Y; Chen Q
    Ann Transl Med; 2022 Mar; 10(6):295. PubMed ID: 35434016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes.
    He J; Li W; Li Y; Liu G
    Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
    Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
    Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 18. High expression of glycolysis-related
    Yu H; Yu Z; Qin C; Bian T; Shi M
    J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (
    Zhao X; Li L; Li Y; Liu Y; Wang H; Tabrizi NS; Ye Z; Zhao Z
    Transl Cancer Res; 2024 Aug; 13(8):4485-4499. PubMed ID: 39262456
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H
    Front Oncol; 2023; 13():1274439. PubMed ID: 38152367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.